Johnson & Johnson

Johnson & Johnson recalling birth control pill Cilest

06 Jun 2013

The struggling US healthcare major is recalling about 32 million packages of its birth control pill Cilest in Europe, Asia and Latin America

Johnson & Johnson recalls children’s Tylenol in South Korea

06 May 2013

The South Korean regulator says that the recall was issued after the company  delayed the recall by a month and flouted quality-control regulations

Johnson & Johnson’s plant licence revoked on quality concerns

04 May 2013

According to the FDA, the J&J plant at Mulund, near Mumbai, has been using ethylene oxide, a harmful chemical, in place of steam to sterilize baby power

Johnson & Johnson weighs sale of Women's Health division: report

28 Jan 2013

J & J to pay $181 million to settle Risperdal's illegal marketing claims

31 Aug 2012

Genmab in $1.1-bn onco drug licencing deal with Johnson & Johnson

30 Aug 2012

Janssen licences diabetes research from Evotec and Harvard University

11 Jul 2012

Johnson & Johnson to set aside $600 mn for Risperdal lawsuits settlement

09 Jun 2012

Lawsuits spur J&J to stop sales of vaginal mesh implants

06 Jun 2012

Johnson & Johnson’s $21 billion bid for Synthes gets EU nod

19 Apr 2012

Forest Laboratories buys hypertension drug rights from J&J for $357 mn

02 Apr 2012

J&J offers EU concessions for $21.3 bn takeover of medical device firm Synthes

23 Feb 2012

Rejected in the US, J&J sells hip implant overseas

16 Feb 2012

European regulator launches antitrust probe against Novartis and J&J

24 Oct 2011

J&J unit wins lawsuit over antibiotic Levaquin drug side effects

15 Oct 2011

Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million

29 Sep 2011

Johnson & Johnson recalls anaemia drug Eprex in 17 countries

24 Sep 2011

J&J is recalling around 200,000 syringes of the anemia drug Eprex in 17 countries due to inconsistent potency in dosages

J&J's Jansen to sell Ortho Dermatologics to Valeant for $345 mn

16 Jul 2011

EU regulator approves Eli Lilly’s acquisition of J&J’s animal health unit

07 Jul 2011

J&J to buy J B Chemicals’ Russian OTC drugs for $260 million

24 May 2011

J&J to buy Swiss medical devices maker Synthes for $21.3 billion

27 Apr 2011

Johnson & Johnson expects the acquisition to create the world's most innovative and comprehensive orthopaedics business

J&J may buy Synthes in $20-bn deal

16 Apr 2011

Eli Lilly to acquire Johnson & Johnson’s animal health unit

15 Mar 2011

Johnson & Johnson mulls fresh assault on Smith & Nephew: report

17 Jan 2011

J&J’s McNeil unit sells St Joseph's aspirin brand to Ilex Consumer Products

08 Jan 2011